Crystalline forms of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)- 5-trifluoromethyl-phenyl]-3-(4-pyridin-3yl-pyrimidin-2-ylamino)-benzamide

Details for Australian Patent Application No. 2006276204 (hide)

Owner Novartis AG

Inventors Brozio, Jorg; Karpinski, Piotr H.; Sutton, Paul Allen; Shieh, Wen-Chung; Wu, Raeann; Manley, Paul W.; Monnier, Stephanie

Agent Davies Collison Cave

Pub. Number AU-A-2006276204

PCT Pub. Number WO2007/015870

Priority 60/716,214 12.09.05 US; 60/701,405 20.07.05 US

Filing date 18 July 2006

Wipo publication date 8 February 2007

International Classifications

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

14 February 2008 PCT application entered the National Phase

  PCT publication WO2007/015870 Priority application(s): WO2007/015870

26 May 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006276205-Salts of 4-methyl-n-[3-(4-methyl-imidazol-1-yl)-5 -trifluoromethylphenyl]-3-(4-pyridin-3-yl-pyrimidin-2-yla mino)-benzamide

2006276202-Fiber optic adapter module